FUS-mediated HypEVs: Neuroprotective effects against ischemic stroke.

Wu, Yousheng; Huang, Xiaoxiong; Tan, Zefeng; Zang, Jiankun; Peng, Min; He, Niu; Zhang, Tao; Mai, Hongcheng; Xu, Anding; Lu, Dan

Wu, Yousheng; Huang, Xiaoxiong; Tan, Zefeng; Zang, Jiankun; Peng, Min; He, Niu; Zhang, Tao; Mai, Hongcheng; Xu, Anding; Lu, Dan.

Afiliación

Wu Y; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Huang X; Clinical Neuroscience Institute, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Tan Z; Key Lab of Guangzhou Basic and Translational Research of Pan-vascular Diseases, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Zang J; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Peng M; Clinical Neuroscience Institute, The First Affiliated Hospital of Jinan University, Guangzhou, China.
He N; Department of Neurology and Stroke Center, The Central Hospital of Shaoyang, Hunan, China.
Zhang T; Department of Neurology, The First People's Hospital of Foshan, Guangdong, China.
Mai H; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Xu A; Clinical Neuroscience Institute, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Lu D; Key Lab of Guangzhou Basic and Translational Research of Pan-vascular Diseases, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Bioact Mater ; 29: 196-213, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37621770

Palabras clave

FUS; Hypoxia; Mitochondrial mRNA; Neuron-derived small extracellular vesicle; Neuroprotection

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Bioact Mater Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google